KRX Growth Leaders With High Insider Ownership In July 2024

The South Korean market has experienced a notable upswing, rising 6.5% over the past year with earnings projected to grow by 30% annually. In this context, stocks like those of growth companies with high insider ownership can be particularly compelling, as they often reflect a deep commitment from those most familiar with the company's potential and operations.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
ALTEOGEN (KOSDAQ:A196170)	26.6%	73.1%
Seojin SystemLtd (KOSDAQ:A178320)	28.0%	58.7%
Fine M-TecLTD (KOSDAQ:A441270)	17.3%	36.4%
Global Tax Free (KOSDAQ:A204620)	18.1%	72.4%
Park Systems (KOSDAQ:A140860)	33%	35.6%
Vuno (KOSDAQ:A338220)	19.5%	105%
UTI (KOSDAQ:A179900)	34.1%	122.7%
HANA Micron (KOSDAQ:A067310)	20%	96.3%
INTEKPLUS (KOSDAQ:A064290)	16.3%	77.4%
Techwing (KOSDAQ:A089030)	18.7%	77.8%

Click here to see the full list of 80 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

EO Technics

Simply Wall St Growth Rating: ★★★★★☆

Overview: EO Technics Co., Ltd. is a global manufacturer and supplier of laser processing equipment, with a market capitalization of approximately ₩2.47 billion.

Operations: The firm operates primarily in the laser processing equipment sector on a global scale.

Insider Ownership: 30.7%

EO Technics, a South Korean company, exhibits strong growth prospects with its revenue forecast to increase by 25.2% annually, significantly outpacing the local market's 10.8%. However, its profit margins have declined from last year's 16.4% to 11%, and earnings growth is expected at a robust rate of 48.3% per year. Despite these promising financials, challenges include a highly volatile share price and large one-off items affecting earnings quality. There’s no recent insider trading information available.

• Delve into the full analysis future growth report here for a deeper understanding of EO Technics.

• Our comprehensive valuation report raises the possibility that EO Technics is priced higher than what may be justified by its financials.

KOSDAQ:A039030 Earnings and Revenue Growth as at Jul 2024

PharmaResearch

Simply Wall St Growth Rating: ★★★★☆☆

Overview: PharmaResearch Co., Ltd. is a biopharmaceutical company based in South Korea, operating with its subsidiaries and has a market capitalization of approximately ₩1.52 billion.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling approximately ₩280.29 billion.

Insider Ownership: 39.1%

PharmaResearch, a South Korean growth company with high insider ownership, is poised for substantial development. Its revenue growth at 16.6% annually surpasses the local market average of 10.8%, though it trails behind the desired 20% threshold. Analysts predict a significant stock price increase of 26.9%. Despite this, its earnings growth projection lags behind the broader Korean market at 20.9% compared to 29.7%. Additionally, the company's share price has shown high volatility recently.

• Dive into the specifics of PharmaResearch here with our thorough growth forecast report.

• Our valuation report unveils the possibility PharmaResearch's shares may be trading at a discount.

KOSDAQ:A214450 Earnings and Revenue Growth as at Jul 2024

Doosan

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Doosan Corporation operates in heavy industry, machinery manufacturing, and apartment construction across various global regions including South Korea, the United States, Asia, the Middle East, and Europe, with a market capitalization of approximately ₩3.72 billion.

Operations: The company's revenue is derived from heavy industry, machinery manufacturing, and apartment construction across diverse regions such as South Korea, the United States, Asia, the Middle East, and Europe.

Insider Ownership: 38.9%

Doosan Corporation, a South Korean company with significant insider ownership, has shown a robust turnaround in its financial performance, reporting substantial improvements in sales and net income for Q1 2024. Despite trading at 55.8% below its estimated fair value and forecasts for profitability within three years, the expected revenue growth of 3.5% per year is modest compared to the market average of 10.8%. Additionally, while earnings are anticipated to grow significantly at an annual rate of 72.88%, the share price remains highly volatile.

• Take a closer look at Doosan's potential here in our earnings growth report.

• Upon reviewing our latest valuation report, Doosan's share price might be too pessimistic.

KOSE:A000150 Earnings and Revenue Growth as at Jul 2024

Summing It All Up

• Access the full spectrum of 80 Fast Growing KRX Companies With High Insider Ownership by clicking on this link.

• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.

• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include KOSDAQ:A039030 KOSDAQ:A214450 and KOSE:A000150.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com